A DRIVE-AB survey to gather information on the global incidence of infections caused by selected antibiotic-resistant bacteria is now available. The results of this survey will be made available to public health officials and researchers to provide a basis for decision-making regarding the prevention, control, and treatment of infections by drug-resistant organisms. To read more or to complete the survey, please click here. ...Read more
DRIVE-AB congratulates Work Package 1A partner Céline Pulcini on receiving the prestigious European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Young Investigator Award. Pulcini, a professor in infectious diseases in Nancy, France is not only an integral member of the DRIVE-AB WP1A team, responsible use of antibiotics, new and old, but is also secretary of (the ESCMID Study Group for Antibiotic Policies), and coordinates the Antimicrobial Stewardship working group of the French infectious diseases society (SPILF). Céline will officially receive her award during the...Read more
DRIVE-AB partner Prof Otto Cars, Uppsala University, has been formally nominated by the United Nations (UN) Secretary General to serve as an expert to the UN ad-hoc Interagency Coordination Group on Antimicrobial Resistance (ICG-AMR). The group is currently being established in response to the UN Declaration to combat AMR that was made in September 2016 to provide practical guidance on action to address the issue of AMR globally and to supervise the implementation of the commitments and tasks that were mandated in the Declaration. Click here to read more on this story.
The World Health Organization (WHO), with some assistance from DRIVE-AB, among others, has recently published their first ever Priority Pathogen List: a catalogue of 12 antibiotic-resistant families of bacteria that pose the greatest threat to human health. The catalogue was developed to guide and promote research and development of new antibiotics as part of the WHO's efforts to address the global threat of antibiotic resistance. Epidemiological data derived from the work of DRIVE-AB Work Package 1B, "Setting, communicating and revising public health priorities", was used as basis for evidence-based criteria for the List. To read more from...Read more
The Boston Consulting Group (BCG) has published a follow-up report for the German Global Union for Antibiotics Research and Development (GUARD) Initiative, “Breaking through the wall: A call for concerted action on antibiotics research and development” in February 2017. It provides detail on four key levers as possible actionable policy instruments; target product profiles, a global research fund, a global development fund and a global launch reward. Click here to read the full report. ...Read more